Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Reviva Pharmaceuticals Hldg Inc (RVPH)

Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Reviva Pharmaceuticals Hldg Inc 10080 N. WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 USA

www.revivapharma.com Employees: 15 P: 408-501-8881 F: 408-904-6270

Description:

Reviva Pharmaceuticals Inc. is a clinical stage pharmaceutical company. It engages in developing therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company's lead product candidate includes RP5063, for the treatment of schizophrenia, bipolar disorder and major depressive disorder. Reviva Pharmaceuticals Inc., formerly known as Tenzing Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 33,441
Enterprise Value, $K 10,071
Shares Outstanding, K 33,441
Annual Sales, $ 0 K
Annual Net Income, $ -39,260 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,860 K
EBIT, $ -36,750 K
EBITDA, $ -36,750 K
60-Month Beta -0.05
% of Insider Shareholders 27.18%
% of Institutional Shareholders 63.18%
Float, K 24,352
% Float 72.82%
Short Volume Ratio 0.70

Growth:

1-Year Return -77.04%
3-Year Return -61.06%
5-Year Return -87.25%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 08/14/24
Next Earnings Date 11/12/24 [--]
Earnings Per Share ttm -1.30
EPS Growth vs. Prev Qtr -4.00%
EPS Growth vs. Prev Year 52.73%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RVPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -280.50%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.22
Interest Coverage -3.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar